Wells Fargo Maintains Overweight on Edwards Lifesciences, Raises Price Target to $121

Benzinga · 2d ago
Wells Fargo analyst Larry Biegelsen maintains Edwards Lifesciences (NYSE:EW) with a Overweight and raises the price target from $113 to $121.